
DB818
CAS No. 790241-43-9
DB818 ( —— )
产品货号. M28983 CAS No. 790241-43-9
DB818是一种合成的同源框A9 (HOXA9)抑制剂,可用于治疗与HOXA9过表达相关的急性髓系白血病的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3029 | 有现货 |
![]() ![]() |
10MG | ¥4528 | 有现货 |
![]() ![]() |
25MG | ¥7752 | 有现货 |
![]() ![]() |
50MG | ¥11664 | 有现货 |
![]() ![]() |
100MG | ¥17658 | 有现货 |
![]() ![]() |
200MG | ¥26892 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称DB818
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述DB818是一种合成的同源框A9 (HOXA9)抑制剂,可用于治疗与HOXA9过表达相关的急性髓系白血病的研究。
-
产品描述DB818 is a synthetic Homeobox A9 (HOXA9) inhibitor and can be used for research on the treatment of acute myeloid leukaemia associated with HOXA9 overexpression.(In Vitro):In the three AML cell lines, DB818 suppressed growth, induced apoptosis, and down-regulated the expression of HOXA9 transcriptional target genes: MYB proto-oncogene, transcription factor (MYB), MYC proto-oncogene, bHLH transcription factor (MYC), and BCL2 apoptosis regulator (BCL2), while up-regulating that of Fos proto-oncogene, AP-1 transcription factor subunit (FOS). HOXA9 knockdown showed similar effects, except for MYC expression, which differed between DB818-treated and HOXA9-deficient OCI/AML3 cells, suggesting an off-target effect of DB818.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number790241-43-9
-
分子量360.44
-
分子式C19H16N6S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESNC(c(cc1)cc2c1nc(-c1ccc(-c3ccc(/C=N\N)cc3)s1)[nH]2)=N
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Tomani JCD, et al. In Vitro Antiplasmodial and Cytotoxic Activities of Compounds from the Roots of Eriosema montanum Baker f. (Fabaceae). Molecules. 2021 May 10;26(9):2795.
产品手册




关联产品
-
Methysticin b
Methysticin, a major kavalactone extracted from kava, can induce CYP1A1.
-
Erythromycin A enol ...
红霉素 A 烯醇醚是大环内酯类抗生素红霉素 A 的降解产物。
-
Potassium 1-Naphthal...
1-萘乙酸酯用作植物生长调节剂,影响分生孢子萌发、孢子形成、菌丝生长、细胞表面形态和某些真菌植物病原体的活力。